Magnetic resonance imaging for prostate cancer: Comparative studies including radical prostatectomy specimens and template transperineal biopsy
暂无分享,去创建一个
N. Lawrentschuk | D. Bolton | A. Ryan | L. Toner | M. Weerakoon | Nikolas Katelaris | Andrew J. Ryan
[1] Tristan Barrett,et al. Defining the learning curve for multiparametric magnetic resonance imaging (MRI) of the prostate using MRI‐transrectal ultrasonography (TRUS) fusion‐guided transperineal prostate biopsies as a validation tool , 2016, BJU international.
[2] J. Fütterer,et al. Can Clinically Significant Prostate Cancer Be Detected with Multiparametric Magnetic Resonance Imaging? A Systematic Review of the Literature. , 2015, European urology.
[3] N. Lawrentschuk,et al. Transperineal biopsy prostate cancer detection in first biopsy and repeat biopsy after negative transrectal ultrasound‐guided biopsy: the Victorian Transperineal Biopsy Collaboration experience , 2015, BJU International.
[4] Werner Jaschke,et al. Evaluation of the PI-RADS scoring system for mpMRI of the prostate: a whole-mount step-section analysis , 2015, World Journal of Urology.
[5] C. Stief,et al. Preoperative mp-MRI of the prostate provides little information about staging of prostate carcinoma in daily clinical practice , 2015, World Journal of Urology.
[6] P. Acher,et al. Diagnostic accuracy of magnetic resonance imaging (MRI) prostate imaging reporting and data system (PI‐RADS) scoring in a transperineal prostate biopsy setting , 2015, BJU international.
[7] F. Fraggetta,et al. Accuracy of 3 Tesla pelvic phased-array multiparametric MRI in diagnosing prostate cancer at repeat biopsy. , 2014, Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica.
[8] Rajan T. Gupta,et al. Comparing 3-T multiparametric MRI and the Partin tables to predict organ-confined prostate cancer after radical prostatectomy. , 2014, Urologic oncology.
[9] N. Lawrentschuk,et al. P007 Transperineal biopsy prostate cancer detection in first biopsy and post-negative TRUS biopsy settings: The Victorian transperineal biopsy collaboration experience , 2014 .
[10] D. Moses,et al. Multiparametric magnetic resonance imaging guided diagnostic biopsy detects significant prostate cancer and could reduce unnecessary biopsies and over detection: a prospective study. , 2014, The Journal of urology.
[11] F. Schröder,et al. Prospective study of diagnostic accuracy comparing prostate cancer detection by transrectal ultrasound-guided biopsy versus magnetic resonance (MR) imaging with subsequent MR-guided biopsy in men without previous prostate biopsies. , 2014, European urology.
[12] O. Rouvière,et al. Characterization of prostate lesions as benign or malignant at multiparametric MR imaging: comparison of three scoring systems in patients treated with radical prostatectomy. , 2014, Radiology.
[13] Evis Sala,et al. Prostate cancer: performance characteristics of combined T2W and DW-MRI scoring in the setting of template transperineal re-biopsy using MR-TRUS fusion , 2014, European Radiology.
[14] Shyam Natarajan,et al. The role of magnetic resonance imaging in delineating clinically significant prostate cancer. , 2014, Urology.
[15] Hessel Wijkstra,et al. The role of magnetic resonance imaging (MRI) in focal therapy for prostate cancer: recommendations from a consensus panel , 2014, BJU international.
[16] Jurgen J Fütterer,et al. Accuracy of multiparametric MRI for prostate cancer detection: a meta-analysis. , 2014, AJR. American journal of roentgenology.
[17] H. Ahmed,et al. Multiparametric Magnetic Resonance Imaging in the Management and Diagnosis of Prostate Cancer: Current Applications and Strategies , 2014, Current Urology Reports.
[18] Peter Kirkbride,et al. Prostate cancer: summary of updated NICE guidance , 2014, BMJ : British Medical Journal.
[19] H. Ahmed,et al. The accuracy of multiparametric MRI in men with negative biopsy and elevated PSA level—Can it rule out clinically significant prostate cancer? , 2014, Urologic oncology.
[20] U. Patel. Histology core‐specific evaluation of the European Society of Urogenital Radiology (ESUR) standardised scoring system of multiparametric magnetic resonance imaging (mpMRI) of the prostate , 2013, BJU international.
[21] L. Kiemeney,et al. The predictive value of endorectal 3 Tesla multiparametric magnetic resonance imaging for extraprostatic extension in patients with low, intermediate and high risk prostate cancer. , 2013, The Journal of urology.
[22] A. Rosenkrantz,et al. 3.0 T multiparametric prostate MRI using pelvic phased-array coil: utility for tumor detection prior to biopsy. , 2013, Urologic oncology.
[23] M Emberton,et al. Performance of multiparametric MRI in men at risk of prostate cancer before the first biopsy: a paired validating cohort study using template prostate mapping biopsies as the reference standard , 2013, Prostate Cancer and Prostatic Disease.
[24] N. Lawrentschuk,et al. The role of magnetic resonance imaging in the diagnosis and management of prostate cancer , 2013, BJU international.
[25] Jan van der Meulen,et al. Multiparametric MR imaging for detection of clinically significant prostate cancer: a validation cohort study with transperineal template prostate mapping as the reference standard. , 2013, Radiology.
[26] Satoru Takahashi,et al. Efficacy of Using Three-Tesla Magnetic Resonance Imaging Diagnosis of Capsule Invasion for Decision-Making About Neurovascular Bundle Preservation in Robotic-Assisted Radical Prostatectomy , 2013, Korean journal of urology.
[27] P. P. Iu,et al. ESUR prostate MR guidelines. , 2013, European radiology.
[28] Rajan T. Gupta,et al. The state of prostate MRI in 2013. , 2013, Oncology.
[29] N. Shah,et al. The role of 1.5 Tesla magnetic resonance imaging in staging prostate cancer , 2013, ANZ journal of surgery.
[30] M. Roobol,et al. Active surveillance for low-risk prostate cancer worldwide: the PRIAS study. , 2013, European urology.
[31] Emilie Niaf,et al. Influence of imaging and histological factors on prostate cancer detection and localisation on multiparametric MRI: a prospective study , 2013, European Radiology.
[32] J. Babb,et al. Impact of delay after biopsy and post-biopsy haemorrhage on prostate cancer tumour detection using multi-parametric MRI: a multi-reader study. , 2012, Clinical radiology.
[33] J. Fütterer,et al. ESUR prostate MR guidelines 2012 , 2012, European Radiology.
[34] Baris Turkbey,et al. Multiparametric 3T prostate magnetic resonance imaging to detect cancer: histopathological correlation using prostatectomy specimens processed in customized magnetic resonance imaging based molds. , 2011, The Journal of urology.
[35] G. Haber,et al. Role of magnetic resonance imaging before initial biopsy: comparison of magnetic resonance imaging‐targeted and systematic biopsy for significant prostate cancer detection , 2011, BJU international.
[36] A. Wein,et al. Campbell-Walsh Urology , 2011 .
[37] François Cornud,et al. Multiparametric magnetic resonance imaging for the detection and localization of prostate cancer: combination of T2‐weighted, dynamic contrast‐enhanced and diffusion‐weighted imaging , 2011, BJU international.
[38] J. Trachtenberg,et al. MRI for men undergoing active surveillance or with rising PSA and negative biopsies , 2010, Nature Reviews Urology.
[39] A. Evans,et al. ‘Prostatic evasive anterior tumours’: the role of magnetic resonance imaging , 2010, BJU international.
[40] P. Choyke,et al. Prostate cancer: value of multiparametric MR imaging at 3 T for detection--histopathologic correlation. , 2010, Radiology.
[41] Mark Emberton,et al. THE ROLE OF MAGNETIC RESONANCE IMAGING IN TARGETING PROSTATE CANCER IN PATIENTS WITH PREVIOUS NEGATIVE BIOPSIES AND ELEVATED PROSTATE‐SPECIFIC ANTIGEN LEVELS , 2009, BJU international.
[42] Neil Fleshner,et al. The role of magnetic resonance imaging in targeting prostate cancer in patients with previous negative biopsies and elevated prostate‐specific antigen levels , 2009, BJU international.
[43] M. Sumura,et al. Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer , 2008, Acta radiologica.
[44] Jerome Marley,et al. Campbell‐Walsh Urology, 9th Edition (E‐dition) ‐ Edited by AJ Wein, LR Kavoussi, AC Novick, AW Partin and CA Peters , 2007 .
[45] A. Villers,et al. Dynamic contrast enhanced, pelvic phased array magnetic resonance imaging of localized prostate cancer for predicting tumor volume: correlation with radical prostatectomy findings. , 2006, The Journal of urology.
[46] T. Stamey,et al. Zonal Distribution of Prostatic Adenocarcinoma: Correlation with Histologic Pattern and Direction of Spread , 1988, The American journal of surgical pathology.
[47] Yipeng Hu,et al. The PICTURE study -- prostate imaging (multi-parametric MRI and Prostate HistoScanning™) compared to transperineal ultrasound guided biopsy for significant prostate cancer risk evaluation. , 2014, Contemporary clinical trials.
[48] A. Rosenkrantz,et al. Prostate imaging reporting and data system (PI-RADS): reflections on early experience with a standardized interpretation scheme for multiparametric prostate MRI. , 2014, AJR. American journal of roentgenology.
[49] Thomas Hambrock,et al. Transition zone prostate cancer: detection and localization with 3-T multiparametric MR imaging. , 2013, Radiology.